🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Beclometasone Dipropionate 200 µg + Formoterol Fumarate 6 µg

Found 16 matching trials

Non-inferiority Evaluation of Trimbow in Critically Ill Patients Admitted in ICU Compared to Standard of Care

PHASE4

Objective: To evaluate non-inferiority of Trimbow, an approved therapy for ...

Status

Unknown

Location

Multiple Locations

Start Date

2021-02-15

Trial ID

NCT04737655

Treatments Being Tested

TRIMBOW® pressurised inhalation solution: Beclometasone dipropionate / formoterol fumarate /glycopyrronium 87/5/9 µg per inhalation

A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

PHASE3

Compare the superiority of CHF 1535 versus CHF 718 in subjects with asthma ...

Status

Completed

Location

Chiesi Clinical Trial Site 840858

Start Date

2022-08-31

Trial ID

NCT05292586

Treatments Being Tested

Beclomethasone Dipropionate/Formoterol Fumarate Beclomethasone Dipropionate

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

PHASE2

The aim of this exploratory investigation is to evaluate if the Forced Expi...

Status

Completed

Location

Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Street Medical Centre

Start Date

2008-02

Trial ID

NCT01343745

Treatments Being Tested

BDP/formoterol BDP/formoterol Placebo

Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

PHASE1

The study is being conducted to compare the pharmacokinetic (PK) of BDP (an...

Status

Completed

Location

SGS Belgium NV - Clinical Pharmacology Unit

Start Date

2023-04-24

Trial ID

NCT05898984

Treatments Being Tested

Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI Reference product 1 (R1): CHF 5993 BDP/FF/GB 100/6/12.5 µg pMDI Reference product 2 (R2): BDP HFA (QVAR REDIHALER®, BDP 80 μg)

Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients

PHASE3

Primary objective To show the superiority of CHF 1535 (BDP/FF) pMDI (800/2...

Status

Completed

Location

Chiesi Clinical Trial Site

Start Date

2012-04-20

Trial ID

NCT01577082

Treatments Being Tested

CHF1535 200/6 µg pMDI BDP HFA 100 µg pMDI

Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children

PHASE2

The purpose of this clinical study is to compare the improvement in breathi...

Status

Completed

Location

Poradnia Alergologiczna

Start Date

2011-12

Trial ID

NCT01584492

Treatments Being Tested

beclomethasone+formoterol 50/6 (1 inhalation)CHF 1535 50/6 (2 inhalations)CHF 1535 50/6 (4 inhalations)Formoterol + Beclomethasone dipropionate Placebo (6 inhalations)

Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD

PHASE3

To evaluate the 1-year efficacy and safety of the fixed combination beclome...

Status

Completed

Location

Thomas Similowski

Start Date

2006-12

Trial ID

NCT00476099

Treatments Being Tested

Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI Budesonide 200 µg plus formoterol 6 µg DPI Formoterol 12 µg DPI

A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma

PHASE3

To demonstrate that CHF 1535 via NEXT DPI (beclomethasone dipropionate + fo...

Status

Completed

Location

Oliver Kornmann - National Coordinator in Germany

Start Date

2009-02

Trial ID

NCT00862394

Treatments Being Tested

BDP/Formoterol Next DPI Foster BDP/Formoterol Next DPI Foster

Study in Adult Patients With Moderate to Severe Asthma

PHASE3

This study assessed the influence of pink vs. white pressurized metered-dos...

Status

Completed

Location

Chiesi Clinical Trial Site 38011

Start Date

2022-02-24

Trial ID

NCT04886999

Treatments Being Tested

Beclomethasone dipropionate 100 µg / Formoterol fumarate 6 µg (Inhaler A)Beclomethasone dipropionate 100 µg / Formoterol fumarate 6 µg (Inhaler B)

Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

PHASE2

The rationale is to investigate the systemic availability of BDP/B17MP and ...

Status

Completed

Location

BorneAstmaKlinikken

Start Date

2009-09

Trial ID

NCT01848769

Treatments Being Tested

CHF1535 pMDI + AC Plus BDP + AC Plus Formoterol + AC Plus

Previous Next